We then compared the frequencies of CSF-infiltrating CD28+ CD27+, CD28+ CD27-, CD28- CD27+, and CD28- CD27- EM CD4+ T cells in patients with MS and controls. This evidence concerns the gene CD4 and myeloid sarcoma.